Rising Demand for Genomics Studies to Drive the Global Optical Genome Mapping Market

 

Global Optical Genome Mapping Market

Optical genome mapping is a new technology used for whole genome mapping to enable precision diagnostics of genetic diseases. Optical mapping utilizes optical microscopy to capture images of elongated, individual DNA molecules to determine their physical arrangement (map), including structural variants and epigenetic features. It helps in characterizing the whole genome architecture of an organism and provides important insights about genetic variation and disease association. The technology has applications in cancer research, personalized medicine, and human genome mapping projects. Advantages of optical genome mapping over conventional genome sequencing methods include its ability to detect complex structural variations, epigenetic features as well as complete circular genomes of bacteria and plasmids. Growing prevalence of genetic disorders and cancer along with increasing focus on precision medicine is driving the demand for genomic studies, fueling the growth of the optical genome mapping market.

The Global Optical Genome Mapping Market is estimated to be valued at US$ 109.9 MN in 2024 and is expected to exhibit a CAGR of 21 % over the forecast period 2024 To 2031.

Key Takeaways

Key players operating in the Global Optical Genome Mapping Market are Bionano Genomics, Nucleome Informatics Private Limited, Praxis Genomics, LLC, SourceBio International Limited (Source BioScience), MedGenome, INRAE (French Plant Genomic Resources Center (CNRGV)), PerkinElmer (PerkinElmer Genomics), Genohub Inc., Hofkens Lab, and Cerba.

Growing demand for personalized medicine, cancer research, and prenatal diagnosis of genetic diseases is a major factor driving the optical genome mapping market. Advancements in technology allowing for high-throughput analysis, target identification and treatment strategies is fueling the adoption of optical genome mapping.

Technological developments such as integration of artificial intelligence and machine learning algorithms for big data analysis of optical maps, development of portable devices for point-of-care applications, and integration of optical mapping with other OMICs technologies will further expand the application scope of optical genome mapping.

Market Trends

Growing Focus on Targeted Therapies: Optical genome mapping helps in detection of disease-causing structural variants to guide development of targeted therapies. This is driving increased R&D investments and adoption.
Integration with Other OMICs: Vendors are developing integrated platforms to perform multi-omics analysis from a single sample using sequencing, optical mapping and epigenomic analysis. This is improving diagnostics and research applications.

Market Opportunities

Personalized Medicine: Growing focus on precision diagnostics and tailored treatment regimens will drive adoption of optical genome mapping in clinical settings to characterize disease-associated genomic alterations.
Cancer Research: Ability to detect complex mutations driving tumor heterogeneity provides opportunities in cancer predisposition testing, liquid biopsies and therapeutic target identification.

Impact of COVID-19 on Optical Genome Mapping Market Growth
The coronavirus pandemic has significantly impacted the growth of the global optical genome mapping market. In the initial months of the pandemic during 2020-2021, countries imposed nationwide lockdowns to curb the virus spread. This led to the temporary closure of research institutes, academic institutes and laboratories where optical genome mapping techniques are majorly used. This resulted in reduced demand for optical genome mapping solutions during this period.

The restrictions on travel and transportation also disrupted the supply chain to some extent. It led to delays in procurement of raw materials and shipment of finished products. This posed challenges for the market players to fulfill the existing orders on time during the peak pandemic phase. However, with gradual lifting of lockdowns and restarting of research activities from mid-2021, the market saw recovery in demand.

The pandemic also highlighted the importance of conducting research on genetic variations and epidemiology of viruses. It created increased focus on using advanced optical genome mapping for genetics research, infectious disease diagnostics, pathogen detection and vaccine development. The market players strategized to target these new application areas to accelerate growth post-pandemic. They also strengthened their online support and remote consulting services to minimize disruption. With resuming economic activities worldwide, the optical genome mapping market is anticipated to regain growth momentum in the coming years.

Regions with Highest Concentration in Optical Genome Mapping Market
In terms of value, North America currently holds the largest share in the global optical genome mapping market. Presence of major market players, advanced research infrastructure, increasing funding for genetic research and growing focus on precision medicine have been driving higher adoption of optical genome mapping techniques in the region.

Asia Pacific is emerging as the fastest growing regional market for optical genome mapping. Countries like China, Japan, South Korea and India are witnessing rapid economic growth and increasing healthcare investments. Expanding biotech industry, rising R&D expenditure on life science research and growing awareness about genetic disorders are fueling the adoption of optical genome mapping in the Asia Pacific region.

Fastest Growing Region in Optical Genome Mapping Market
Asia Pacific region is poised to witness the fastest growth in the optical genome mapping market during the forecast period from 2024 to 2031. This can be attributed to factors like - increasing government funding for genomics research, rapidly developing healthcare infrastructure, rising healthcare expenditure, growing efforts to sequence human genomes, expanding biopharmaceutical industry and presence of emerging economies like India and China driving higher investments in life science research. Moreover, growing incidence of genetic diseases and cancer and rising awareness levels regarding precision medicine offer huge potential for optical genome mapping services in Asia Pacific.

Get more insights on Global Optical Genome Mapping Market